Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FRUQUINTINIB vs FUROSEMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FRUQUINTINIB vs FUROSEMIDE: Safety Overview

Metric FRUQUINTINIB FUROSEMIDE
Total FAERS Reports 2,565 51,843
Deaths Reported 874 6,131
Death Rate 34.1% 11.8%
Hospitalizations 753 30,446
Average Patient Age 63.9 yrs 68.8 yrs
% Female Patients 44.4% 53.2%
FDA Approval Date Nov 8, 2023 Approved Prior to Jan 1, 1982
Manufacturer Takeda Pharmaceuticals America, Inc. Hospira, Inc.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Discontinued